🔗 Share this article

A shadow market for unlicensed slimming drugs is propelled by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.

Experimental Treatment Gaining Traction Via Social Media

The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its supposed fat-burning properties. Viewers are encouraged to message these accounts privately for supplier links, while also obtaining promotional offers.

Active Trade on Messaging Platforms

Separately, a robust market exists on Telegram, where communities with numerous of members share “before and after” images, administration instructions and claims of rapid British shipping. Vendors market the substance there before redirecting buyers to WhatsApp for transactions.

Learning About The Experimental Drug

Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help patients lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic.

Healthcare Professionals Express Worries

However, doctors and chemists have warned that the distribution of what is still an unapproved medication in the United Kingdom is worrisome and could lead to individuals administering substances of uncertain source.

Several professionals said the popularity for the experimental drug could be linked to the rising cost of licensed weight loss treatments such as Mounjaro.

Regulatory Status and Enforcement

Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unapproved medication that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.

Some content creators try to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still violate pharmaceutical, advertising, and customer laws, potentially leading to fines, legal action or prison.

Service Reaction and Content Elimination

Based on the social media company, the service has removed problematic content and banned related hashtags and query recommendations. The organization said it was dedicated to keeping the service secure and allocating resources in enhancing compliance measures.

Digital Trading Activities

Research also discovered groups with up to nine thousand participants marketing retatrutide using Telegram's built-in search feature, which functions like a public directory. Typing “retatrutide” immediately brings up groups with thousands of users, filled with images of slimming results, glowing reviews and step-by-step instructions for preparing or injecting at home.

After minutes of entering one group, a seller shared WhatsApp details, where most transactions take place. The vendor provided an instruction manual and guaranteed shipping within two days. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None asked about weight, health issues or past usage.

Product Details and Costs

Within these communities, messages show dark colored packages with postal service stickers, stating to include new batches. One message read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at home with purified liquid, or pre-filled pens usually priced at 160 pounds for 20mg. When asked how much time a injector should last, vendors give conflicting responses varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Measures

A spokesperson for Telegram stated it regularly monitored dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are administering substances they can’t verify. Although the science behind this drug is valid, these digital versions may not include what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to recent price rises for approved weight-loss drugs such as Mounjaro. “With prices rising, individuals are using online platforms. But counterfeit injections are extremely risky. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she explained.

Her team has already seen patients harmed by personal administration from unverified suppliers. “We recognize the frustration, but buying from Telegram or WhatsApp is taking chances with your health,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Statement

A spokesperson from the pharmaceutical company stated retatrutide was in third stage research studies and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may subject users to potentially significant medical dangers”.